
Moderna Inc
NASDAQ:MRNA

Wall Street
Price Targets
MRNA Price Targets Summary
Moderna Inc
According to Wall Street analysts, the average 1-year price target for
MRNA
is 51.1 USD
with a low forecast of 20.2 USD and a high forecast of 222.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MRNA's stock price target?
Price Target
51.1
USD
According to Wall Street analysts, the average 1-year price target for
MRNA
is 51.1 USD
with a low forecast of 20.2 USD and a high forecast of 222.6 USD.
What is Moderna Inc's Revenue forecast?
Projected CAGR
1%
For the last 7 years the
compound annual growth rate for
Moderna Inc's revenue is
48%.
The projected
CAGR
for the next 3 years is
1%.